1 GOOD MORNING! BONJOUR! GOEDEMORGEN!. 2 An Introduction to certain aspects of the US FDA Murray M. Lumpkin, MD Deputy Commissioner International Programs.
Approach to Outcome Measure Development or Selection: A Regulatory Perspective Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials.
Introduction to Biostatistics, Harvard Extension School, Fall, 2005 © Scott Evans, Ph.D.1 Clinical Trials.
